Dr. Anju Nabi
President-ESCM

Dr. Arun Kumar Jha
Chair, Conference Organizing & Cultural Committee-ESCM

We are pleased to extend an invitation to the 4^th Annual International Conference of the Emirates Society of Clinical Microbiology (ESCM). The conference is scheduled to take place from November 15^th to 17^th2024, at RAK Medical & Health Sciences University in Ras Al Khaimah, UAE.

Our aim is to bring together experts from various clinical and non-clinical domains to exchange their latest findings, guidelines, and experiences.

The Scientific Committee has developed a comprehensive program that includes keynote lectures, oral and poster sessions, as well as interactive workshops. We encourage you to participate in all the informative educational, social, and professional events that ESCM has to offer.

This conference presents a valuable opportunity to connect with fellow ESCM members, colleagues, researchers, technologists, nurses, students, and other professionals in microbiology, immunology, infectious diseases, infection control, public health, and related fields. Additionally, you will have the chance to interact with representatives from various companies and industries operating in this area.

We have an impressive line-up of international and national speakers who will share their knowledge and evidence-based findings aimed at enhancing patient care quality and safety, while strengthening the discipline of clinical microbiology in the United Arab Emirates.

We believe that your participation will greatly enrich the conference experience.

We look forward to your presence at the 4^th Annual International Conference of ESCM in Ras Al Khaimah from November 15^th to 17^th 2024.

The 4th Annual International Conference of the Emirates Society of Clinical Microbiology (ESCM) offers an interactive platform for students & professionals to present their research.
This year, we are excited to invite poster and oral presentations around topics related to Respiratory pathogens; COVID-19; Healthcare associated infections; Emerging and Re-emerging viral infections; Transplant infectious diseases; Advances in rapid diagnostics; One Health for all; Malaria and other vector borne infections; Antimicrobial resistance; Surveillance of Antimicrobial resistance & WHONET; Antimicrobial stewardship; Fungal infections; Surveillance of fungal diseases; Tuberculosis and Mycobacteria; Genome sequencing/NGS; Human microbiome: Clinical implications; New antimicrobials; Artificial intelligence in Clinical Microbiology; any other Clinical Microbiology topics.

Abstract submission deadline: Sunday, 06 October 2024. Tuesday, 08 October 2024 – 11:59 PM (GST).
Notification on Acceptance/Rejection: Thursday, 10 October 2024 – 11:59 PM (GST) Thursday, 17 October 2024 – 11:59 PM (GST).

To submit an abstract, please read all of the instructions below:

Category of Abstracts
Student abstracts, such as:

• Undergraduates
• Post-graduates
• PhDs

Professionals abstracts, such as:

• Postdoctoral fellow
• Other Microbiology Professional

Topics Accepted

• Bacteriology
• Virology
• Mycology
• Microbiome
• Other microbiology related topics

Language
All abstracts must be submitted in English using the online submission form on the 3rd ESCM Conference www.ESCM.ae/4th-Conference

General conditions

1. Please note that only electronic submissions through the abstract submission website are accepted.
2. Abstracts must be submitted by Sunday, 06 October. Tuesday, 08 October 2024 – 11:59 PM (GST). Abstracts received after this time will not be accepted for judging.
3. Abstracts must be submitted in English.
4. Withdrawal of abstracts can only be accepted if notified in writing. It is possible to withdraw an abstract 7 days after notification on acceptance.
5. If selected, it is the responsibility of the presenter to bear registration, travel and accommodation expenses.
6. All correspondence relating to scientific abstracts will be undertaken by email with the first named author.
7. Entrants will be advised no later than 15 October 2023 – 11:59 PM (GST), on the acceptance of rejection of their abstracts.
8. Student abstracts will be selected for ‘Poster’ presentation only.
9. Non-student abstracts that will not be selected for ‘Oral’ presentations shall be offered to be presented as ‘Poster’ presenter.
10. Email for clarifications regarding abstract submission: ESCMScientificCommittee@gmail.com

Presenting Author and Registration

1. Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.
2. Disclosure: The abstract submitter and presenter are required to disclose any conflict of interest.
3. Ensure that all co-authors approve the abstract submission, publication, and potential presentation.
4. At least one of the named authors or all co-authors of an abstract must be a registered paying delegate for the conference they are submitting their abstract for, to be able to present the abstract. Registrations must be received by Friday, 25 October 2024.
   
5. The scientific committee reserves the right to exclude any abstract that is not followed by a participant registration at the latest 7 days after notification of acceptance.

Contents of your abstract

1. Scientific abstracts are limited to 350 words* from the `Introduction’ to the ‘References’ fields inclusive.
   *Please do not include the title and the author & co-authors’ (up to 5) information in the text body (names and affiliations). This information will be required in the web form
2. Abstracts uploaded should only be submitted in the Microsoft Word format, single-spaced, using size 12 Times New Roman font.
3. Abstracts should highlight major points of your research and explain why your work is important; what your purpose was, what you learned, and what you concluded.
4. The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS. No full stop at the end. The title of the abstract during the Poster or Oral presentation at the conference should be the same as the title on the submitted abstract.
5. The abstract must include the following:
   > Introduction (including Background & Objectives)
   > Methodology (including Materials; Methods & Study Design)
   > Results
   > Discussion
   > Conclusions
   > References
6. All abbreviations must be defined in first use.
7. No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit the abstract online.
8. Statements such as “results will be discussed” or “data will be presented” cannot be accepted.
9. By submitting an abstract, the authors confirm that the abstract is their own original work, is not defamatory or unlawful and does not infringe anyone else’s rights.
10. All abstracts must reflect an original work. An abstract should not be submitted if the work was published/presented at a major national or international meeting prior to the 3rd CA-ESCM
11. No amendments or additions to abstracts or authors can be made once your abstract has been submitted. Please ensure that all information is correct and all authors are listed when submitting
12. Please note that all submissions are subject to proof reading and editing

Decisions

1. Judges appointed by the Scientific Committee will assess and judge scientific abstracts for both e-poster and oral presentations.
2. To avoid any conflict of interest, a “blind” review process will be used.
3. The decision of the judges is final.

Prizes
>Poster Abstract Awards: Awards will be given for each category of posters (Undergraduates, Post-graduates, PhDs, Post-docs and Professionals).
>Oral Abstract Awards: The best two oral presentations will be awarded.

Strategic Partner